Chemours (CC) Payables (2014 - 2026)

Chemours' Payables history runs 13 years deep, the most recent figure standing at $891.0 million for Q1 2026.

• On a quarterly basis, Payables fell 11.43% year-over-year to $891.0 million in Q1 2026; TTM through Mar 2026 was $891.0 million, a 11.43% decrease from a year earlier, with the FY2025 full-year figure at $929.0 million, down 19.64% from the prior year.
• Payables declined to $891.0 million in Q1 2026 per CC's latest filing, from $929.0 million in the prior quarter.
• Across five years, Payables topped out at $1.3 billion in Q3 2022 and bottomed at $885.0 million in Q3 2023.
• The 5-year median for Payables is $1.0 billion (2025), against an average of $1.1 billion.
• Across the five-year window, Payables plunged 30.31% in 2023 and increased 21.81% in 2024, its largest moves.
• Year by year, Payables stood at $1.2 billion in 2022, then decreased by 6.28% to $1.1 billion in 2023, then climbed by 1.94% to $1.2 billion in 2024, then declined by 19.64% to $929.0 million in 2025, then declined by 4.09% to $891.0 million in 2026.
• Per Business Quant, the three latest CC Payables figures stand at $891.0 million (Q1 2026), $929.0 million (Q4 2025), and $1.0 billion (Q3 2025).